Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #124619 on Amarantus Bioscience Holdings Inc (AMBS)
GoClippers
04/24/16 8:47 PM
#124620 RE: Inoviorulez #124619
Because when Rubenfield signed on board he thought the company would advance MANF, Lympro, Eltoprazine. He never saw that the CEO would switch to ESS. First of all ESS is a dermatolgoy indication what does that have to do with Neurology? Parkinson's, Alzheimer's, etc.